• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Melina Schuh awarded the EMBL Alumni John Kendrew Award 2015

Melina Schuh awarded the EMBL Alumni John Kendrew Award 2015

Melina Schuh awarded the EMBL Alumni John Kendrew Award 2015

Published on 19 December, 2014

Melina Schuh, from the LMB’s Cell Biology Division, has been awarded the EMBL Alumni John Kendrew Young Scientist Award for 2015. The award recognises excellence in science and/or science communication by any pre- or post-doctoral alumni of EMBL, up to 7 years after they have left EMBL. Melina was a PhD student in the EMBL […]

Michel Goedert awarded the 2014 European Grand Prix for Research

Published on 19 December, 2014

Michel Goedert, Joint Head of the LMB’s Neurobiology Division, has been awarded the European Grand Prix for Research by the Foundation for Research on Alzheimer’s disease based in Paris. Michel has been awarded the Prize for “his major work on the importance of the tau pathway in the genesis of Alzheimer’s disease” and for “the […]

Sjors Scheres named by Nature as one of ten people who mattered in 2014

Published on 18 December, 2014

LMB group leader Sjors Scheres is profiled by Nature as one of its ten people of the year, for his work on bringing the cell’s molecular machines into sharper focus, with the use of cryo-EM. More…

LMB raises over £1,200 for “Mind in Cambridgeshire”

Published on 18 December, 2014

Staff at the LMB have raised over £1,200 from their annual charity fundraiser for Mind in Cambridgeshire, a dynamic, county-wide charity that supports local people in their recovery from mental health issues, promoting wellbeing and campaigning against stigma and discrimination. This cause was chosen to complement the work being done by the LMB’s Mental Health […]

Heptares Therapeutics granted key patents for GPCR-Focused Drug Discovery Platform

Published on 17 December, 2014

Heptares Therapeutics, a leading G protein-coupled receptor (GPCR) structure-guided drug discovery company, has recently been granted multiple key patents in the USA. GPCRs are a superfamily of drug receptors linked to a wide range of human diseases and Heptares was founded in 2007 to develop and commercialise pioneering research from the LMB and the National […]

Golden grids for electron cryo-microscopy

Published on 12 December, 2014

Recent exciting advances in electron cryo-microscopy (cryo-EM) have allowed scientists to find very detailed structures of some proteins. Still, determining the structure of many proteins remains too difficult for cryo-EM, as the images are too noisy to use for structure determination. Lori Passmore and Chris Russo from the LMB’s Structural Studies Division have designed new […]

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 251
  • Page 252
  • Page 253
  • Page 254
  • Page 255
  • Interim pages omitted …
  • Page 327
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.